Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles

Xin Wang1, Xiaoyu Li1, Jing Ma2

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China.

Virus Research
|July 20, 2014
PubMed

Insights

The APOBEC3F protein

Area of Science:

  • Molecular Biology
  • Virology
  • Biochemistry

Background:

  • APOBEC3 proteins are key antiviral factors against retroviruses, with APOBEC3G (hA3G) and APOBEC3F (hA3F) showing potent anti-HIV-1 activity.
  • Efficient antiviral function of hA3F requires its incorporation into HIV-1 virions, but the underlying mechanism is not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms governing the viral packaging of APOBEC3F (hA3F).
  • To identify specific regions and residues within HIV-1 Gag and hA3F essential for hA3F virion incorporation.

Main Methods:

  • Detailed mapping studies were performed to pinpoint regions within hA3F and HIV-1 Gag involved in virion encapsidation.
  • Functional assays were used to assess the role of specific protein domains, linker sequences, and residues in hA3F incorporation.

Main Results:

  • The nucleocapsid (NC) domain of HIV-1 Gag and a specific linker sequence (amino acids 104-156) in hA3F are crucial for hA3F viral packaging.
  • A cluster of basic residues near the N-terminal zinc finger (ZF) and the inter-ZF linker of HIV-1 NC are important for hA3F incorporation.
  • At least one of the two ZFs in HIV-1 NC is necessary for hA3F incorporation, and a fragment of hA3F can compete with both hA3G and hA3F for packaging.

Conclusions:

  • Identified specific domains and residues in HIV-1 Gag NC and hA3F that mediate hA3F virion incorporation.
  • Suggests a common mechanism for the virion encapsidation of APOBEC3G (hA3G) and APOBEC3F (hA3F) into HIV-1 particles.
  • Provides critical insights into the molecular basis of hA3F antiviral activity against HIV-1.